The synthesis of broccoli sprout extract-loaded silk fibroin nanoparticles as efficient drug delivery vehicles : development and characterization
Targeted drug delivery of biological molecules using the development of biocompatible, non-toxic and biodegradable nanocarriers can be a promising method for cancer therapy. In this study, silk fibroin protein nanoparticles (SFPNPs) were synthesized as a targeted delivery system for sulforaphane-rich broccoli sprout extract (BSE). The BSE-loaded SFPNPs were conjugated with polyethylene glycol and folic acid, and then their physicochemical properties were characterized via UV-Vis, XRD, FTIR, DLS, FE-SEM and EDX analyses. In vitro, the release profile, antioxidant and anticancer activities of NPs were also studied. The FE-SEM and DLS analyses indicated stable NPs with an average size of 88.5 nm and high zeta potential (-32 mV). The sulforaphane release profile from NPs was pH-dependent, with the maximum release value (70%) observed in simulated intestinal fluid (pH = 7.4). Encapsulation of BSE also decreased the release rate of sulforaphane from the capsules compared to free BSE. In vitro cytotoxicity of BSE and NPs on breast cancer cell lines (MCF-7) was concentration-dependent, and the IC50 for BSE and NPs were 54 and 210 μg ml-1, respectively. Moreover, the NPs demonstrated no appreciable cytotoxicity in normal mouse fibroblast (L929) cell lines. These results indicated that biocompatible NPs synthesized as controlled and long-term targeted drug delivery systems can be a potential candidate for breast cancer therapy.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
---|---|
Enthalten in: |
Pharmaceutical development and technology - (2024) vom: 08. Apr., Seite 1-12 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ghanbari Hassan Kiadeh, Saeed [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anticancer activity |
---|
Anmerkungen: |
Date Revised 08.04.2024 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1080/10837450.2024.2336101 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM370359933 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM370359933 | ||
003 | DE-627 | ||
005 | 20240408232905.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240329s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/10837450.2024.2336101 |2 doi | |
028 | 5 | 2 | |a pubmed24n1369.xml |
035 | |a (DE-627)NLM370359933 | ||
035 | |a (NLM)38546461 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ghanbari Hassan Kiadeh, Saeed |e verfasserin |4 aut | |
245 | 1 | 4 | |a The synthesis of broccoli sprout extract-loaded silk fibroin nanoparticles as efficient drug delivery vehicles |b development and characterization |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 08.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a Targeted drug delivery of biological molecules using the development of biocompatible, non-toxic and biodegradable nanocarriers can be a promising method for cancer therapy. In this study, silk fibroin protein nanoparticles (SFPNPs) were synthesized as a targeted delivery system for sulforaphane-rich broccoli sprout extract (BSE). The BSE-loaded SFPNPs were conjugated with polyethylene glycol and folic acid, and then their physicochemical properties were characterized via UV-Vis, XRD, FTIR, DLS, FE-SEM and EDX analyses. In vitro, the release profile, antioxidant and anticancer activities of NPs were also studied. The FE-SEM and DLS analyses indicated stable NPs with an average size of 88.5 nm and high zeta potential (-32 mV). The sulforaphane release profile from NPs was pH-dependent, with the maximum release value (70%) observed in simulated intestinal fluid (pH = 7.4). Encapsulation of BSE also decreased the release rate of sulforaphane from the capsules compared to free BSE. In vitro cytotoxicity of BSE and NPs on breast cancer cell lines (MCF-7) was concentration-dependent, and the IC50 for BSE and NPs were 54 and 210 μg ml-1, respectively. Moreover, the NPs demonstrated no appreciable cytotoxicity in normal mouse fibroblast (L929) cell lines. These results indicated that biocompatible NPs synthesized as controlled and long-term targeted drug delivery systems can be a potential candidate for breast cancer therapy | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Silk fibroin protein | |
650 | 4 | |a anticancer activity | |
650 | 4 | |a broccoli sprout extract | |
650 | 4 | |a drug delivery | |
650 | 4 | |a nanoparticles | |
650 | 4 | |a sulforaphane | |
700 | 1 | |a Rahaiee, Somayeh |e verfasserin |4 aut | |
700 | 1 | |a Azizi, Hossein |e verfasserin |4 aut | |
700 | 1 | |a Govahi, Mostafa |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pharmaceutical development and technology |d 1998 |g (2024) vom: 08. Apr., Seite 1-12 |w (DE-627)NLM094740194 |x 1097-9867 |7 nnns |
773 | 1 | 8 | |g year:2024 |g day:08 |g month:04 |g pages:1-12 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/10837450.2024.2336101 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2024 |b 08 |c 04 |h 1-12 |